REINNERVATE
LIVE

Serial Number

79094022

Owner

Reinnervate Limited

Attorney

Miriam D. Trudell

Filing Date

Sep 7, 2010

Add to watchlist:

No watchlists yet
View on USPTO

REINNERVATE Trademark

Serial Number: 79094022 • Registration: 4100733

REINNERVATE is a trademark filed by Reinnervate Limited on September 7, 2010. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 40 (Treatment & Processing), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Reinnervate Limited (5 trademarks)

Old Shire Hall Old Elvet

Entity Type: 99

Trademark Details

Filing Date

September 7, 2010

Registration Date

February 21, 2012

Published for Opposition

December 6, 2011

Cancellation Date

September 7, 2020

Goods & Services

Education services, namely, provision of training, arranging and conducting of seminars and workshops all in the fields of biology, biotechnology, cell culture, cell biology, toxicity and safety testing, tissue and disease modelling and drug efficacy; on-line non-downloadable electronic publications, namely, bulletins and journal articles in the fields of biology, biotechnology, cell culture, cell biology, toxicity and safety testing, tissue and disease modelling and drug efficacy

Batch biological and chemical treatment services of materials; batch biological and chemical material treatment involving cell culture processes and the differentiation of cell types; treatment of human, animal and plant cells, bacteria and antibody materials by culturing such cells in three dimensions; material treatment involving three dimensional cell culture processes and in-vitro stem cell differentiation

Cell culture apparatus and instruments for laboratory or research medical use; laboratory apparatus, namely, cell culture vessels, multiwell plates, petri dishes, cell culture well inserts, cell factories, cell culture flasks and bioreactors for use in the separation of antibodies; reaction units, namely, cell based assays, routine cell cultures, cell passaging and perfusion cell culture systems containing chemical or biological reagents; cell culture scaffolds, namely, microspun fibres and microporous polystyrene substrates coated with extra-cellular matrices; deep well plates, namely, deep reservoir petri dishes with and without well insert cradles used in laboratory research

Pharmaceutical preparations for the treatment of skin and neuro-degenerative diseases; medical biological reagents for use in molecular biology; medical diagnostic reagents; medical diagnostic reagents for in vitro laboratory tests; chemical reagents for medical and veterinary purposes; chemical preparations, agents and reagents for medical and veterinary use, namely, in the differentiation of cell types; biological preparations for the treatment of skin and neuro-degenerative diseases; cell growth media for growing cells for medical or clinical use; diagnostic agents, preparations and substances for medical purposes, namely, for use in binding or detecting antibodies, and in the development of antibodies

Biological preparations for use in the induction of cell differentiation in cell cultures and synthetic small molecules for use in the induction of in-vitro cell differentiation, other than medical; cell growth media for growing cells for use in scientific research; media for cell culture for use, namely, in non-medical research and biotechnological laboratories; chemical preparations for biotechnological purposes, namely, for the induction of cell differentiation, in particular stem cell differentiation; reagents for use in scientific apparatus for chemical or biological analysis; chemical preparations, agents and reagents for use in cellular research; biochemicals, namely, monoclonal antibodies other than for medical or veterinary purposes; biochemicals, namely, antibodies for diagnostic, laboratory, industrial or scientific use other than medical; biochemical products containing antibodies for use in scientific research

Scientific research and design services in the field of three dimensional cell culture and analytical processes; industrial analysis and research services in the field of cell culture, cell biology, toxicity and safety testing, tissue and disease modelling and drug efficacy; laboratory services, namely, analysis and research in the field of cell and tissue cultures and their treatment; biotechnology research; laboratory services relating to the production of antibodies; growing cell cultures for research purposes; testing pharmaceutical, medical and biological agents for others; consultancy relating to biotechnology

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Sep 25, 2021 DENC
DEATH OF INTERNATIONAL REGISTRATION
Sep 25, 2021 DETH
TOTAL INVALIDATION PROCESSED BY THE IB
Nov 30, 2019 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Jun 22, 2019 INTS
INVALIDATION PROCESSED
Jun 22, 2019 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
May 28, 2019 INTR
CANCELLED SECTION 71
Sep 28, 2018 C71T
NEW REPRESENTATIVE AT IB RECEIVED
Sep 29, 2017 NREP
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Feb 21, 2017 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 22, 2012 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 5, 2012 FICS
FINAL DISPOSITION PROCESSED
Sep 4, 2012 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 21, 2012 FICR
REGISTERED-PRINCIPAL REGISTER
Feb 21, 2012 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 6, 2011 NPUB
PUBLISHED FOR OPPOSITION
Dec 6, 2011 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 16, 2011 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Oct 28, 2011 PREV
ASSIGNED TO LIE
Oct 28, 2011 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 30, 2011 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 22, 2011 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 22, 2011 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 22, 2011 TROA
REFUSAL PROCESSED BY IB
Apr 17, 2011 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 30, 2011 RFCS
REFUSAL PROCESSED BY MPU
Mar 30, 2011 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 30, 2011 RFCR
NON-FINAL ACTION WRITTEN
Mar 29, 2011 CNRT
APPLICATION FILING RECEIPT MAILED
Mar 26, 2011 MAFR
ASSIGNED TO EXAMINER
Mar 22, 2011 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 22, 2011 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 17, 2011 REPR